Full Text View
Tabular View
No Study Results Posted
Related Studies
Phenotype/Genotype Correlations in Movement Disorders
This study is currently recruiting participants.
Verified by National Institutes of Health Clinical Center (CC), July 2008
First Received: July 7, 2001   Last Updated: June 9, 2009   History of Changes
Sponsored by: National Institute of Neurological Disorders and Stroke (NINDS)
Information provided by: National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier: NCT00018889
  Purpose

The goal of this protocol is to identify families with inherited movement disorders and evaluate disease manifestations to establish an accurate clinical diagnosis by using newest technological advances and investigate the underlying molecular mechanisms. Studies of inherited movement disorders in large families with good genealogical records are especially valuable. Patients with diseases of known molecular basis will be genotyped in order to investigate phenotype/genotype correlation. Patients with disease of unknown or incomplete genetic characterization will be studied with a hope of contributing to the identification of specific disease-causing genes and genetic mechanisms responsible for a specific disorder.


Condition
Movement Disorder

Study Type: Observational
Official Title: Phenotype/Genotype Correlations in Movement Disorders

Resource links provided by NLM:


Further study details as provided by National Institutes of Health Clinical Center (CC):

Estimated Enrollment: 500
Study Start Date: July 2001
Estimated Study Completion Date: March 2004
Estimated Primary Completion Date: March 2004 (Final data collection date for primary outcome measure)
Detailed Description:

The goal of this protocol is to identify families with inherited movement disorders and evaluate disease manifestations to establish an accurate clinical diagnosis by using newest technological advances and investigate the underlying molecular mechanisms. Studies of inherited movement disorders in large families with good genealogical records are especially valuable. Patients with diseases of known molecular basis will be genotyped in order to investigate phenotype/genotype correlation. Patients with disease of unknown or incomplete genetic characterization will be studied with a hope of contributing to the identification of specific disease-causing genes and genetic mechanisms responsible for a specific disorder.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria
  • INCLUSION CRITERIA:

Individuals with known or suspected inherited movement disorders.

Families where multiple family members that are affected with a movement disorder.

EXCLUSION CRITERIA:

Pregnant women will be excluded from any tests involving radiation treatment.

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00018889

Contacts
Contact: Patient Recruitment and Public Liaison Office (800) 411-1222 prpl@mail.cc.nih.gov
Contact: TTY 1-866-411-1010

Locations
United States, Maryland
National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting
Bethesda, Maryland, United States, 20892
Sponsors and Collaborators
  More Information

Additional Information:
No publications provided

Study ID Numbers: 010206, 01-N-0206
Study First Received: July 7, 2001
Last Updated: June 9, 2009
ClinicalTrials.gov Identifier: NCT00018889     History of Changes
Health Authority: United States: Federal Government

Keywords provided by National Institutes of Health Clinical Center (CC):
Clinical Evaluation
Genetic Study
Essential Tremor
Familial Myoclonus
Hereditary Ataxia
Essential Tremor
Familial Myoclonus
Hereditary Ataxia
Movement Disorder
Inherited Movement Disorder

Study placed in the following topic categories:
Essential Tremor
Myoclonus
Movement Disorders
Ataxia
Central Nervous System Diseases
Benign Essential Tremor Syndrome
Hereditary Ataxia
Tremor

Additional relevant MeSH terms:
Pathologic Processes
Disease
Movement Disorders
Nervous System Diseases
Central Nervous System Diseases

ClinicalTrials.gov processed this record on July 02, 2009